ArticleJournal of medical case reports2026
Thyrotropin/growth hormone co-secreting pituitary adenoma with pancytopenia: a case report.
Article in Journal of medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundThyroid-stimulating hormone (TSH)-secreting pituitary adenoma (TSHoma) is a rare functional pituitary tumor that secretes TSH independently, thus stimulating the synthesis and secretion of thyroid hormone. Its clinical manifestation is central hyperthyroidism, and it is easily misdiagnosed as Graves' disease. At present, the treatment of TSHoma includes surgery, medication, and radiotherapy, and transsphenoidal pituitary surgery remains the first-line treatment. CASE PRESENTATION: This case involved a 61-year-old Chinese male with clinical manifestations of weight loss, heart palpitations, and shortness of breath, both thyroid hormone and TSH are elevated. The patient was diagnosed with a TSH/growth hormone (GH) co-secreting pituitary adenoma by serological examination, magnetic resonance imaging of the pituitary gland, and related functional tests. Due to thrombocytopenia and heart disease, the patient was deemed a poor candidate for immediate surgery and was therefore treated with octreotide. Thyroid function tests normalized after medication, and the diagnosis of TSHoma was verified.
conclusionAlthough TSHoma is rare, it is not difficult to diagnose based on clinical presentation, ancillary examination, and functional testing. Thyroid hormone resistance syndrome is very similar to it and is therefore easily misdiagnosed. Early diagnosis and appropriate treatment can effectively control the disease and even achieve a clinical cure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.